-
11.
公开(公告)号:KR1020040087356A
公开(公告)日:2004-10-14
申请号:KR1020030021537
申请日:2003-04-07
Applicant: 재단법인서울대학교산학협력재단
IPC: C12N9/64
CPC classification number: C12N9/6472 , C12N15/74 , C12Y304/22068
Abstract: PURPOSE: SUMO-specific protease, mUlpB from mouse brain and gene thereof are provided, which are useful for development of anticancer drugs including acute leukemia. CONSTITUTION: The SUMO-specific protease, mUlpB is isolated from mouse brain, wherein the SUMO-specific protease digests protein or peptide bound to SUMO; the SUMO-specific protease has the total or portion of the amino acid sequence of SEQ ID NO:2; and the SUMO-specific protease has molecular weight of 55 kDa. The SUMO-specific protease gene has the total or portion of the nucleotide sequence of SEQ ID NO:1. The expression plasmids pET32a-mUIpB and pCMV-Tag-mUIpB contain the total or portion of the nucleotide sequence of SEQ ID NO:1. A transformant is produced by transforming microorganism BL21 with the expression plasmid pET32a-mUIpB.
Abstract translation: 目的:提供SUMO特异性蛋白酶,来自小鼠脑的mUlpB及其基因,其可用于开发抗癌药物,包括急性白血病。 构成:SUMO特异性蛋白酶mUlpB从小鼠脑中分离,其中SUMO特异性蛋白酶消化与SUMO结合的蛋白质或肽; SUMO特异性蛋白酶具有SEQ ID NO:2的氨基酸序列的全部或部分; 并且SUMO特异性蛋白酶的分子量为55kDa。 SUMO特异性蛋白酶基因具有SEQ ID NO:1的核苷酸序列的全部或部分。 表达质粒pET32a-mUIpB和pCMV-Tag-mUIpB含有SEQ ID NO:1的核苷酸序列的全部或部分。 通过用表达质粒pET32a-mUIpB转化微生物BL21产生转化体。